These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 39273511

  • 1. Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation.
    Juanes-Velasco P, Arias-Hidalgo C, García-Vaquero ML, Sotolongo-Ravelo J, Paíno T, Lécrevisse Q, Landeira-Viñuela A, Góngora R, Hernández ÁP, Fuentes M.
    Int J Mol Sci; 2024 Sep 03; 25(17):. PubMed ID: 39273511
    [Abstract] [Full Text] [Related]

  • 2. Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.
    Mohan SV, Datta KK, Ziegman R, Smith C, Gowda H.
    STAR Protoc; 2021 Mar 19; 2(1):100385. PubMed ID: 33778779
    [Abstract] [Full Text] [Related]

  • 3. IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation.
    Goncalves G, Mullan KA, Duscharla D, Ayala R, Croft NP, Faridi P, Purcell AW.
    Front Immunol; 2021 Mar 19; 12():645770. PubMed ID: 33968037
    [Abstract] [Full Text] [Related]

  • 4. Critical Review of Existing MHC I Immunopeptidome Isolation Methods.
    Kuznetsov A, Voronina A, Govorun V, Arapidi G.
    Molecules; 2020 Nov 19; 25(22):. PubMed ID: 33228004
    [Abstract] [Full Text] [Related]

  • 5. Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
    Pak H, Michaux J, Huber F, Chong C, Stevenson BJ, Müller M, Coukos G, Bassani-Sternberg M.
    Mol Cell Proteomics; 2021 Nov 19; 20():100080. PubMed ID: 33845167
    [Abstract] [Full Text] [Related]

  • 6. In-depth mining of the immunopeptidome of an acute myeloid leukemia cell line using complementary ligand enrichment and data acquisition strategies.
    Pandey K, Mifsud NA, Lim Kam Sian TCC, Ayala R, Ternette N, Ramarathinam SH, Purcell AW.
    Mol Immunol; 2020 Jul 19; 123():7-17. PubMed ID: 32387766
    [Abstract] [Full Text] [Related]

  • 7. FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.
    Weisbrod L, Capriotti L, Hofmann M, Spieler V, Dersch H, Voedisch B, Schmidt P, Knake S.
    Front Immunol; 2024 Jul 19; 15():1386160. PubMed ID: 38779658
    [Abstract] [Full Text] [Related]

  • 8. Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
    Ghosh M, Gauger M, Marcu A, Nelde A, Denk M, Schuster H, Rammensee HG, Stevanović S.
    Mol Cell Proteomics; 2020 Mar 19; 19(3):432-443. PubMed ID: 31937595
    [Abstract] [Full Text] [Related]

  • 9. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
    Shahbazy M, Ramarathinam SH, Illing PT, Jappe EC, Faridi P, Croft NP, Purcell AW.
    Mol Cell Proteomics; 2023 Apr 19; 22(4):100515. PubMed ID: 36796644
    [Abstract] [Full Text] [Related]

  • 10. IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma.
    Wahle M, Thielert M, Zwiebel M, Skowronek P, Zeng WF, Mann M.
    Mol Cell Proteomics; 2024 Jan 19; 23(1):100689. PubMed ID: 38043703
    [Abstract] [Full Text] [Related]

  • 11. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
    Chikata T, Paes W, Akahoshi T, Partridge T, Murakoshi H, Gatanaga H, Ternette N, Oka S, Borrow P, Takiguchi M.
    J Virol; 2019 Sep 01; 93(17):. PubMed ID: 31217245
    [Abstract] [Full Text] [Related]

  • 12. The interdependence of machine learning and LC-MS approaches for an unbiased understanding of the cellular immunopeptidome.
    Nielsen M, Ternette N, Barra C.
    Expert Rev Proteomics; 2022 Feb 01; 19(2):77-88. PubMed ID: 35390265
    [Abstract] [Full Text] [Related]

  • 13. The impact of immunopeptidomics: From basic research to clinical implementation.
    Shapiro IE, Bassani-Sternberg M.
    Semin Immunol; 2023 Mar 01; 66():101727. PubMed ID: 36764021
    [Abstract] [Full Text] [Related]

  • 14. HLA Allele-Specific Quantitative Profiling of Type 1 Diabetic B Lymphocyte Immunopeptidome.
    Sudhir PR, Lin TD, Zhang Q.
    J Proteome Res; 2022 Jan 07; 21(1):250-264. PubMed ID: 34932366
    [Abstract] [Full Text] [Related]

  • 15. New light on the HLA-DR immunopeptidomic landscape.
    Egholm Bruun Jensen E, Reynisson B, Barra C, Nielsen M.
    J Leukoc Biol; 2024 Apr 29; 115(5):913-925. PubMed ID: 38214568
    [Abstract] [Full Text] [Related]

  • 16. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
    Partridge T, Nicastri A, Kliszczak AE, Yindom LM, Kessler BM, Ternette N, Borrow P.
    Front Immunol; 2018 Apr 29; 9():912. PubMed ID: 29780384
    [Abstract] [Full Text] [Related]

  • 17. The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.
    Vizcaíno JA, Kubiniok P, Kovalchik KA, Ma Q, Duquette JD, Mongrain I, Deutsch EW, Peters B, Sette A, Sirois I, Caron E.
    Mol Cell Proteomics; 2020 Jan 29; 19(1):31-49. PubMed ID: 31744855
    [Abstract] [Full Text] [Related]

  • 18. The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire.
    Nicastri A, Liao H, Muller J, Purcell AW, Ternette N.
    Proteomics; 2020 Jun 29; 20(12):e1900401. PubMed ID: 32359108
    [Abstract] [Full Text] [Related]

  • 19. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
    Marcu A, Bichmann L, Kuchenbecker L, Kowalewski DJ, Freudenmann LK, Backert L, Mühlenbruch L, Szolek A, Lübke M, Wagner P, Engler T, Matovina S, Wang J, Hauri-Hohl M, Martin R, Kapolou K, Walz JS, Velz J, Moch H, Regli L, Silginer M, Weller M, Löffler MW, Erhard F, Schlosser A, Kohlbacher O, Stevanović S, Rammensee HG, Neidert MC.
    J Immunother Cancer; 2021 Apr 29; 9(4):. PubMed ID: 33858848
    [Abstract] [Full Text] [Related]

  • 20. Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.
    ElAbd H, Franke A.
    Methods Mol Biol; 2024 Apr 29; 2758():425-443. PubMed ID: 38549028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.